Late Breaking Abstract - Patients with a genomic classifier result positive for UIP show a greater decline in lung function when treated with combination immunosuppressive therapy
A. Wells (London, United Kingdom), C. Ryerson (Vancouver, Canada), L. Lancaster (Nashville, United States), M. Johnson (South San Francisco, United States), J. Huang (South San Francisco, United States), J. Burbanks-Ivey (South San Francisco, United States), E. Morrie (South San Francisco, United States), L. Lofaro (South San Francisco, United States), W. Bulman (South San Francisco, United States), G. Kennedy (South San Francisco, United States), G. Raghu (Seattle, United States), M. Scholand (Salt Lake City, United States)
Source: International Congress 2022 – Promising new approaches in idiopathic interstitial pneumonias
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Wells (London, United Kingdom), C. Ryerson (Vancouver, Canada), L. Lancaster (Nashville, United States), M. Johnson (South San Francisco, United States), J. Huang (South San Francisco, United States), J. Burbanks-Ivey (South San Francisco, United States), E. Morrie (South San Francisco, United States), L. Lofaro (South San Francisco, United States), W. Bulman (South San Francisco, United States), G. Kennedy (South San Francisco, United States), G. Raghu (Seattle, United States), M. Scholand (Salt Lake City, United States). Late Breaking Abstract - Patients with a genomic classifier result positive for UIP show a greater decline in lung function when treated with combination immunosuppressive therapy. 1948
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|